Skip to content
HowShorted

Pebblebrook Hotel Trust short interest in 2023

In 2023, Pebblebrook Hotel Trust's disclosed short interest ran from 9.16% of shares outstanding on 13 Jan 2023 to 15.91% on 29 Dec 2023, a change of +6.75 percentage points. The year's high was 20.94% on 31 Jul 2023 and its low 9.16% on 13 Jan 2023, averaging 15.74% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.01 days on 15 Aug 2023. Full history: Pebblebrook Hotel Trust.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Pebblebrook Hotel Trust in 2023

2023 in figures

Start of year
9.16% (13 Jan 2023)
End of year
15.91% (29 Dec 2023)
Change
+6.75 pp
High
20.94% (31 Jul 2023)
Low
9.16% (13 Jan 2023)
Average
15.74%
Highest days to cover
14.01 (15 Aug 2023)
SEC filings marked
9

Every report in 2023

Pebblebrook Hotel Trust short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20239.16%6.44
31 Jan 202312.08%7.99results (8-K)
15 Feb 202310.34%6.55
28 Feb 202311.98%5.6810-K filed, results (8-K)
15 Mar 202311.64%5.28
31 Mar 202315.72%3.99
14 Apr 202314.56%8.89
28 Apr 202314.06%7.0710-Q filed, results (8-K)
15 May 202314.94%8.62
31 May 202316.97%11.69
15 Jun 202317.30%10.44
30 Jun 202318.33%6.62
14 Jul 202316.60%11.58
31 Jul 202320.94%10.8410-Q filed, results (8-K)
15 Aug 202320.50%14.01
31 Aug 202317.58%12.04
15 Sep 202320.15%12.92
29 Sep 202316.79%12.10
13 Oct 202318.77%13.81
31 Oct 202316.31%9.6810-Q filed, results (8-K)
15 Nov 202315.60%7.26
30 Nov 202315.89%13.73
15 Dec 202315.66%9.57
29 Dec 202315.91%7.75

See also: Pebblebrook Hotel Trust's full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.